Blood-Brain Barrier Impairment in an Animal Model of MPS III B
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sanfilippo syndrome type B (MPS III B) is caused by a deficiency of α-N-acetylglucosaminidase enzyme, leading to accumulation of heparan sulfate within lysosomes and eventual progressive cerebral and systemic multiple organ abnormalities. However, little is known about the competence of the blood-brain barrier (BBB) in MPS III B. BBB dysfunction in this devastating disorder could contribute to neuropathological disease manifestations. METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we investigated structural (electron microscope) and functional (vascular leakage) integrity of the BBB in a mouse model of MPS III B at different stages of disease, focusing on brain structures known to experience neuropathological changes. Major findings of our study were: (1) endothelial cell damage in capillary ultrastructure, compromising the BBB and resulting in vascular leakage, (2) formation of numerous large vacuoles in endothelial cells and perivascular cells (pericytes and perivascular macrophages) in the large majority of vessels, (3) edematous space around microvessels, (4) microaneurysm adjacent to a ruptured endothelium, (6) Evans Blue and albumin microvascular leakage in various brain structures, (7) GM3 ganglioside accumulation in endothelium of the brain microvasculature. CONCLUSIONS/SIGNIFICANCE: These new findings of BBB structural and function impairment in MPS III B mice even at early disease stage may have implications for disease pathogenesis and should be considered in current and future development of treatments for MPS III B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One rami fi cation is that the BBB is compromised in certain neurological diseases (MPS IIIB, Parkinson ' s disease) (193, 194), making the inhibitory effects of NAbs more likely.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Pericytes in the microvasculature
Hirschi, K. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00063-6 · Cited by 775
Díaz‐Flores, L., Gutiérrez, R., Madrid, J. F., Varela, H., Valladares, F., Acosta, E., Martı́n-Vasallo, P., & Díaz-Flores, L. (2009) · PubMed · doi:10.14670/hh-24.909 · Cited by 545
ABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Guillemin, G. J., & Brew, B. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303114 · Cited by 525
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. W. (2003) · Peptide Transport and Delivery into the Central Nervous System · doi:10.1007/978-3-0348-8049-7_2 · Cited by 445
Blood-brain barrier biology and methodology
Pardridge, W. M. (1999) · Journal of Neurovirology · doi:10.3109/13550289909021285 · Cited by 445
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB
Ohmi, K., Greenberg, D. S., Rajavel, K. S., Ryazantsev, S., Li, H. H., & Neufeld, E. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252784899 · Cited by 412
Jeyakumar, M. (2003) · Brain · doi:10.1093/brain/awg089 · Cited by 352
Cited by
Blood–brain barrier structure and function and the challenges for CNS drug delivery
Abbott, N. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9608-0 · Cited by 909
Salvalaio, M., Rigon, L., Belletti, D., D’Avanzo, F., Pederzoli, F., Ruozi, B., Marin, O., Vandelli, M. A., Forni, F., Scarpa, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156452 · Cited by 93
A versatile toolkit for overcoming AAV immunity
Li, X., Wei, X., Lin, J., & Ou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991832 · Cited by 57
Advances in therapies for neurological lysosomal storage disorders
Ellison, S. M., Parker, H., & Bigger, B. (2023) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12615 · Cited by 63
Okuneva, O., Li, Z., Körber, I., Tegelberg, S., Joensuu, T. H., Tian, L., & Lehesjoki, A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0764-7 · Cited by 49
Dwyer, C. A., Scudder, S. L., Lin, Y., Dozier, L. E., Phan, D., Allen, N. J., Patrick, G. N., & Esko, J. D. (2017) · Scientific Reports · doi:10.1038/srep46576 · Cited by 48
Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA
Rozaklis, T., Beard, H., Hassiotis, S., Garcia, A. R., Tonini, M., Luck, A. J., Pan, J., Lamsa, J. C., Hopwood, J. J., & Hemsley, K. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.04.004 · Cited by 42
Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system
Scarpa, M., Bellettato, C. M., Lampe, C., & Begley, D. J. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.12.001 · Cited by 46
Bertalan, G., Klein, C., Schreyer, S., Steiner, B., Kreft, B., Tzschätzsch, H., de Schellenberger, A. A., Nieminen-Kelhä, M., Braun, J., Guo, J., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.011 · Cited by 33
Kowalewski, B., Heimann, P., Ortkras, T., Lüllmann‐Rauch, R., Sawada, T., Walkley, S. U., Dierks, T., & Daμμe, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu603 · Cited by 33
Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases
Story, B. D., Miller, M. E., Bradbury, A. M., Million, E. D., Duan, D., Taghian, T., Faissler, D., Fernau, D., Beecy, S. J., & Gray‐Edwards, H. L. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00080 · Cited by 33
Blood-brain barrier impairment in MPS III patients
Garbuzova-Davis, S. N., Mirtyl, S., Sallot, S. A., Hernandez‐Ontiveros, D. G., Haller, E. M., & Sanberg, P. R. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-174 · Cited by 25
Self-citationA High Fat “Western‐style” Diet Induces AMD‐Like Features in Wildtype Mice
Keeling, E., Lynn, S. A., Koh, Y. M., Scott, J. A., Kendall, A., Gatherer, M., Page, A. M., Cagampang, F. R. A., Lotery, A. J., & Ratnayaka, J. A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100823 · Cited by 24
Wei, X., Wang, D., Li, M., Zhang, Y., Li, Y., & Li, W. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31823498eb · Cited by 25
Baldo, G., Wozniak, D. F., Ohlemiller, K. K., Zhang, Y., Giugliani, R., & Ponder, K. P. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9530-x · Cited by 21
Tironi-Farinati, C., Geoghegan, P. A., Cangelosi, A., Pinto, A., Loidl, C. F., & Goldstein, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055812 · Cited by 20
He, Z., He, B., Behrle, B. L., Fejleh, M. P., Cui, L., Paule, M. G., & Greenfield, L. J. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn2001156 · Cited by 22
van der Meulen, P. M., Barendregt, A. M., Cuadrado, E., Magro‐Checa, C., Steup‐Beekman, G. M., Schonenberg‐Meinema, D., van den Berg, J. M., Li, Q., Baars, P. A., Wouters, D., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex073 · Cited by 21
D’Angelo, B., Ek, C. J., Sandberg, M., & Mallard, C. E. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9551-5 · Cited by 18
Pentosan Polysulfate Treatment of Mucopolysaccharidosis Type IIIA Mice
Guo, N., DeAngelis, V. A., Zhu, C., Schuchman, E. H., & Simonaro, C. M. (2018) · JIMD Reports · doi:10.1007/8904_2018_96 · Cited by 18
Restoring brain barriers: an innovative approach for treating neurological disorders
Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 21
Grover, A., Crippen-Harmon, D., Nave, L., Vincelette, J., Wait, J. C. M., Melton, A. C., Lawrence, R., Brown, J. R.-M., Webster, K. A., Yip, B. K., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00683-6 · Cited by 16
Zaghmi, A., Drouin‐Ouellet, J., Brambilla, D., & Gauthier, M. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120461 · Cited by 17
Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB
Petrova, R., Patil, A. R., Trinh, V., McElroy, K. E., Bhakta, M., Tien, J., Wilson, D. S., Warren, L. L., & Stratton, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-42431-4 · Cited by 15
Veraldi, N., Quadri, I. D., van de Looij, Y., Modernell, L., Sinquin, C., Zykwinska, A., Tournier, B. B., Dalonneau, F., Li, H., Li, J., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121214 · Cited by 12
Hewson, L. J., Choo, A., Webber, D. L., Trim, P. J., Snel, M. F., Fedele, A. O., Hopwood, J. J., Hemsley, K. M., & O’Keefe, L. V. (2024) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12712 · Cited by 5
Immunocytochemical Assessment of Blood–Brain Barrier Structure, Function, and Damage
Louboutin, J. (2015) · Neuromethods · doi:10.1007/978-1-4939-2313-7_13 · Cited by 3
Gene Therapy for Neurodevelopmental Disorders
McCarty, D. M., & Fu, H. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025276 · Cited by 1
Harm, T. A. (2021) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210609-65
Ebine, K., & Ueda, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00154-1
Niño-Traslaviña, K. D., Súarez, D. A., Sánchez, O. F., Espejo-Mojica, A. J., & Alméciga-Díaz, C. J. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04879-4
Rigney, S. (2015) · Dominican Scholar (Dominican University of California) · doi:10.33015/dominican.edu/2015.bio.07
Metadata
- Authors
- Garbuzova-Davis, S., Louis, M. K., Haller, E. M., Derasari, H. M., Rawls, A. E., & Sanberg, P. R.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Garbuzova-Davis, Svitlana
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-07
- Volume
- 6
- Issue
- 3
- Pages
- e16601
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3049764
- OpenAlex
- W2071018996
- Cited by
- 32
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Children's Medical Research
- University of South Florida
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- Sanfilippo syndrome type B, blood-brain barrier dysfunction, heparan sulfate accumulation, endothelial injury, microvascular leakage, pericytes, perivascular macrophages, cerebral microvasculature, mouse model
- MeSH terms
- Acetylglucosaminidase, Albumins, Animals, Blood-Brain Barrier, Disease Models, Animal, Evans Blue, G(M3) Ganglioside, Immunohistochemistry, Mice, Mutant Strains, Mucopolysaccharidosis III, Mice, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.